Pediatric Chronic Skin Disorders Linked to Poorer Mental Health

Children with chronic skin disorders, including atopic dermatitis (AD), psoriasis, vitiligo, alopecia areata, hidradenitis suppurativa, and congenital ichthyosis, face increased rates of anxiety, depression, stigma, and emotional distress compared with their peers, along with effects on health-related quality of life (HRQoL) and family relationships, according to the results of a systematic review published in Frontiers in Pediatrics.

The findings highlight the multidimensional burden of pediatric chronic skin disease and reinforce the need for routine mental health screening in pediatric dermatology.

“These disorders are frequently associated with pruritus, pain, sleep disturbance, and recurrent infections, which interfere with daily activities, school attendance, and peer relationships,” the authors noted. “More importantly, visible skin lesions may provoke social stigma, bullying, and discrimination, leading to social withdrawal and reduced self-esteem.”

Systematic Review for Pediatric Skin Conditions

The authors conducted the review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines, searching PubMed, Scopus, Web of Science, PsycINFO, Cochrane Library, and Embase for literature published between 2010 and 2025 on psychological and HRQoL outcomes in children and adolescents (ages 0-18) with chronic skin disease.

An initial search identified 1844 records, of which 41 met inclusion criteria for the final synthesis. Of those, 75% were cross-sectional, and 12 were rated high methodological quality using the appraisal tools: Joanna Briggs Institute and Critical Appraisal Skills Programme. Due to heterogeneity across study designs and populations, the authors utilized a narrative synthesis approach rather than a pooled statistical analysis.

Psychological Impact in Children with Skin Disease

Children with chronic skin disorders consistently showed elevated rates of anxiety, depression, stigma, and emotional distress. A longitudinal study published in JAMA Dermatology found severe AD was associated with more than double the odds of depressive symptoms and nearly double the odds of internalizing symptoms compared with children without AD.²

Stigma and social visibility were also seen as major contributors to psychological distress. Sleep disturbance, closely tied to itch severity, was frequently reported alongside increased emotional instability. HRQoL deficits clustered around 4 domains: emotional functioning, peer relationships, school participation, and sleep, with worse quality-of-life scores consistently associated with greater disease severity, regardless of the specific condition.¹

Across studies, greater disease severity and symptom burden were associated with worsened mental health outcomes. In children with AD, persistent pruritus and sleep disturbances were commonly linked to emotional distress. Visible lesions and social stigma were identified as risk factors specifically for psoriasis and vitiligo. Additional risk factors included female sex, larger affected body surface area, and disease chronicity. Protective factors included family and peer support, effective disease control, adaptive coping strategies, and access to integrated dermatologic-psychological care.

Mental Strain on Caregivers and Families

Of the 41 included studies, 19 documented effects on caregivers, showing elevated stress, anxiety, disrupted sleep, financial strain, and reduced personal quality of life. Caregivers of children with vitiligo and ichthyosis showed emotional and financial strain, while families of children with AD reported stress and sleep disruption. Caregiver distress tracked closely with the severity of a child's symptoms, underscoring that managing the family is inseparable from managing the child's skin disease.

Cross-Sectional Study Limitations

As 75% of the 41 included studies used a cross-sectional design, measuring disease severity and psychological outcomes at a single point in time rather than tracking children over months or years, the review can show that psychological distress and skin disease consistently occur together, but cannot establish that one causes the other. Only 12 studies were rated high quality, and the studies varied widely in condition, population, and country, which led the authors to rely on narrative synthesis rather than a pooled statistical analysis. Despite these limitations, the review offers meaningful insight into psychosocial outcomes in the pediatric population across a variety of dermatologic conditions.

Integrated Care to Improve Pediatric Dermatology

The authors recommend that mental health screening become a routine part of dermatological visits for children and adolescents. They also call for closer collaboration between dermatologists and mental health providers, alongside family-centered care models, to improve recognition and management of psychological distress, particularly for children with severe, visible, or long-standing skin disease.

Though the evidence is cross-sectional, it points to a strong and consistent association between dermatological conditions and reduced psychological well-being in children and adolescents, including depression, anxiety, stress, low self-esteem, stigma, impaired social functioning, and behavior difficulties.

“Providing assistance for eliminating the stigma attached to dermatological conditions will help improve emotional and quality of life outcomes for affected children, as will assisting in the optimal management of their dermatological disease,” the authors wrote.

References

1. AlKaabba AF, Aldosari SM, Alwadai TA, et al. Psychological impact and quality of life in pediatric patients with chronic skin disorders: a systematic review (2010-2025). Front Pediatr. 2026:14:1821918. doi:10.3389/fped.2026.1821918
2. Kern C, Wan J, LeWinn KZ, et al. Association of atopic dermatitis and mental health outcomes across childhood: a longitudinal cohort study. JAMA Dermatol. 2021;157(10):1200-1208. doi:10.1001/jamadermatol.2021.2657